Test Menu

To order our tests, download and complete the requisition form, then fax form to 615-255-1330.

Contact us to learn more about our upcoming offerings.
 

   

KRAS Gene Mutation Analysis

 

This test detects mutations commonly found in tumors that tend to be unresponsive to treatment with anti-EGFR drugs such as cetuximab, panitumumab, gefitinib and erlotinib.

 

 

EGFR Gene Mutation Analysis

  This test detects the presence of any of 29 different mutations in the tyrosine kinase region of the EGFR gene. These mutations are commonly found in solid tumors especially in lung cancers. Tumors with EGFR mutations tend to respond well to EGFR targeted drugs such as cetuximab, panitumumab, gefitinib and erlotinib.